WO2020091334A1 - 유산균의 동결 보호를 위한 시스테인 또는 이의 염의 용도 - Google Patents
유산균의 동결 보호를 위한 시스테인 또는 이의 염의 용도 Download PDFInfo
- Publication number
- WO2020091334A1 WO2020091334A1 PCT/KR2019/014257 KR2019014257W WO2020091334A1 WO 2020091334 A1 WO2020091334 A1 WO 2020091334A1 KR 2019014257 W KR2019014257 W KR 2019014257W WO 2020091334 A1 WO2020091334 A1 WO 2020091334A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lactic acid
- acid bacteria
- cysteine
- salt
- culture medium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
Definitions
- the present application relates to an active ingredient for freeze protection of lactic acid bacteria and utilization / application of the active ingredient.
- Lactic acid bacteria is also called lactic acid bacteria or lactic acid bacteria, it is an important bacterium that is used as a dressing agent by preventing abnormal fermentation by various bacteria while inhabiting the intestines of mammals.
- lactic acid bacteria in order to exert the effect of bacteria, it is necessary to consume much more lactic acid bacteria than the amount ingested with food such as yogurt. Therefore, it is popular to separate only lactic acid bacteria and eat them conveniently in powder or capsule form.
- the lactic acid bacteria are made into powder or capsule, there are many lactic acid bacteria that die during the long-term distribution process, and thus there is a limitation that the physiologically active functions of the lactic acid bacteria cannot be exerted.
- the present application protects lactic acid bacteria from freezing, while freeze-dried and powdered, a composition for lactic acid bacteria freeze protection or culture medium for lactic acid bacteria freeze protection, and preparation of lactic acid bacteria using the same, which can impart high stability to lactic acid bacteria, for example, thermal stability I want to provide a method.
- the present application is to provide a method for promoting the growth of lactic acid bacteria that can promote the growth of lactic acid bacteria by promoting the growth of lactic acid bacteria, and a culture medium of lactic acid bacteria for excellent growth of lactic acid bacteria.
- one aspect of the present application provides a composition for freeze protection of lactic acid bacteria, comprising cysteine or a salt thereof as an active ingredient.
- another aspect of the present application provides a method for preparing a lactic acid bacteria agent comprising mixing the lactic acid bacteria with the composition for freeze protection of the lactic acid bacteria and pulverizing the mixture.
- another aspect of the present application provides a culture medium for lactic acid bacteria freeze protection, comprising cysteine or a salt thereof as an active ingredient.
- another aspect of the present application provides a method for producing a lactic acid bacteria agent comprising culturing lactic acid bacteria in the culture medium, recovering the cultured lactic acid bacteria, and pulverizing the recovered lactic acid bacteria.
- Another aspect of the present application is lactic acid bacteria; And cysteine or a salt thereof.
- the present application may provide a culture medium for promoting lactic acid bacteria growth, which includes cysteine or a salt thereof as an active ingredient.
- the present application can provide a method for promoting the growth of lactic acid bacteria, comprising culturing lactic acid bacteria in a culture medium of the present application, for example, a culture medium for lactic acid bacteria freeze protection and / or a culture medium for promoting growth of lactic acid bacteria. All.
- the present application may provide a method for regulating energy metabolism of lactic acid bacteria, comprising culturing lactic acid bacteria in a culture medium of the present application, for example, a culture medium for freeze protection of lactic acid bacteria and / or a culture medium for promoting growth of lactic acid bacteria. have.
- the present application can provide a method of increasing the thermal stability of lactic acid bacteria, comprising culturing lactic acid bacteria in a culture medium of the present application, for example, a culture medium for lactic acid bacteria freeze protection and / or a culture medium for promoting growth of lactic acid bacteria. have.
- the active ingredient of the present application not only protects the lactic acid bacteria from freezing, but also has an effect of improving stability so that the lactic acid bacteria can maintain activity to the maximum even after being lyophilized and powdered.
- the cysteine or its hydrochloride has the effect of allowing the lactic acid bacteria, which are alive but stopped to proliferate, to exhibit excellent stability even in a high temperature physical environment due to powdering, thereby facilitating the distribution or storage / storage of the living lactic acid bacteria. There is this.
- lactic acid bacteria are cultured in the culture medium of the present application, for example, a culture medium for freeze protection of lactic acid bacteria and / or a culture medium for promoting growth of lactic acid bacteria
- the growth yield of lactic acid bacteria can be dramatically improved, and also the thermal stability of lactic acid bacteria is dramatically improved. Can be improved.
- the term 'lactic acid bacteria' referred to in the present application is a generic term for bacteria that ferment sugars to obtain energy and produce large amounts of lactic acid.
- the lactic acid bacteria include Lactobacillus sp. , Bifidobacterium sp. , Streptococcus sp. , Lactococcus sp. , Enterococcus sp. , Pediococcus sp. May be one or more selected from the group consisting of the genus Leuconostoc sp. And Weissella sp .
- Lactobacillus plantarum Lactobacillus casei , Lactobacillus rhamnosus , Lactobacillus acidophilus , Lactobacillus acidophilus , Bifidobacterium b. bifidum ), Bifidobacterium longum , Bifidobacterium breve , Streptococcus faecalis , Lactococcus lactis subsp. lactis , and more Specifically, Lactobacillus plantarum CJLP243 ( Lactobacillus plantarum CJLP243 ) disclosed in Korean Patent Registration No.
- Lactobacillus plantarum CJLP133 Lactobacillus plantarum CJLP133
- Korean Patent Registration No. 1,486,999 Korean Registered Patent Publication No. Lactobacillus plantarum CJLP136 disclosed in 1,075,558 , Korea, etc.
- Lock disclosed in Patent Application No. 1.25505 million No. Lactobacillus Planta room CJLP55 (Lactobacillus plantarum CJLP55), Korea register may be a such as Patent No. 1,075,557 Lactobacillus Planta room CJLP56 (Lactobacillus plantarum CJLP56) disclosed in, not particularly limited to, No.
- 'freeze protection' means to protect lactic acid bacteria tissue from freezing when stored by freeze-drying in order to preserve the activity of lactic acid bacteria as they are.
- freeze drying' freezes the material to be dried by rapidly lowering the temperature of the container, then sublimates the solidified solvent contained in the material into water vapor by vacuuming the pressure inside the container. It is a method of drying.
- the freeze-drying is a method of minimizing damage to heat-sensitive materials and effectively preserving them for a long time, and is useful in terms of pollution prevention, storage, transportation, and economics.
- the freezing temperature of freeze drying as described above may be a sub-zero temperature, for example, -40 ° C to -196 ° C (boiling point of liquid nitrogen), -50 ° C to -196 ° C, -70 ° C to -196 ° C,
- a sub-zero temperature for example, -40 ° C to -196 ° C (boiling point of liquid nitrogen), -50 ° C to -196 ° C, -70 ° C to -196 ° C.
- a substance or composition added together during freeze-drying so as to recover its function upon rehydration without damaging or killing lactic acid bacteria is referred to as a 'freeze protection agent' or a 'freeze protection composition' It refers to, and it serves to increase the survival rate by imparting physicochemical stability to lactic acid bacteria.
- the present application provides a composition for lactic acid bacteria freeze protection.
- composition for freeze protection of lactic acid bacteria of the present application contains cysteine or a salt thereof as an active ingredient.
- the cysteine is a kind of sulfur-containing ⁇ -amino acid having a structure of HS-CH 2 CH (NH 2 ) -COOH, and has a sulfhydryl group, thereby forming disulfide bonds with other cysteines.
- the cysteine may be L-cysteine, D-cysteine or L, D-cysteine, and specifically L-cysteine.
- the salt of the cysteine may be any salt of the cysteine, for example, hydrochloride, sulfate, and the like.
- the cysteine or a salt thereof protects the lactic acid bacteria from freezing, thereby minimizing damage or death of the lactic acid bacteria by freezing, and further improving the stability of the lactic acid bacteria so that the lactic acid bacteria can maintain their own activity even after freeze-drying. do. Therefore, the cysteine or a salt thereof may be used not only as an active ingredient of the composition for freeze-protecting lactic acid bacteria, but also as an active ingredient of a composition for improving stability of dried, particularly freeze-dried lactic acid bacteria.
- the cysteine or a salt thereof out of 100% by weight of the total composition, 0.01% by weight or more, for example, one lower limit and / or 10% by weight or less selected from the group consisting of 0.01% by weight, 0.05% by weight and 0.1% by weight, For example, it may be included in a content range consisting of a combination of one upper limit selected from the group consisting of 10% by weight, 7% by weight, 5% by weight, and 3% by weight.
- the cysteine or a salt thereof is contained in an amount of 0.05% to 10% by weight, specifically 0.05% to 7%, 0.05% to 5%, 0.05% to 100% by weight of the total 100% by weight of the composition 3 wt%, or specifically 0.1 wt% to 10 wt%, 0.1 wt% to 7 wt%, 0.1 wt% to 5 wt%, 0.1 wt% to 3 wt% may be included in the content, cysteine as described above, or The content of the salt thereof can be appropriately adjusted by a person skilled in the art according to the type, size, amount of lactic acid bacteria, freeze drying conditions, and the type or content of other components included in the composition.
- composition for freeze protection of lactic acid bacteria of the present application may further include a freeze protection agent, a porous support, or a nitrogen source.
- the cryoprotectant refers to a material having a cryoprotective effect commonly used in the technical field to which this application belongs, except for the cysteine or a salt thereof, and commercially available ones may be purchased and used, and the type is not particularly limited. .
- sugars, amino acids, peptides, gelatin, glycerol, sugar alcohols, whey, alginic acid, ascorbic acid, yeast extract, skim milk, and the like may be used.
- trehalose a type of saccharide, may be used as the cryoprotectant.
- the trehalose is a sugar that is widely present in nature such as plants and microorganisms, and prevents lactic acid bacteria from being damaged or killed by freeze-drying, and serves as a cryoprotectant that helps restore its function when rehydrated. It is known substance.
- the trehalose is 10% by weight to 40% by weight, for example, 10% by weight to 30% by weight, specifically 15% by weight to 25% by weight, and more specifically 17.5% by weight, in 100% by weight of the total composition for lactic acid bacteria freeze protection It may be included in an amount of 22.5% by weight, but the content of the active ingredient contained in the composition for lactic acid bacteria freeze protection, the type, size, amount of lactic acid bacteria, freeze drying conditions, the type or content of other components included in the composition, etc. The technician can adjust accordingly.
- the porous support blocks the inflow of external moisture and air, and imparts porosity to the lyophilized lactic acid bacteria to facilitate rehydration.
- the porous support is a porous support commonly used in freeze-drying in the technical field to which the present application pertains, and commercially available ones can be purchased and used, and the type is not particularly limited.
- the porous support may be maltodextrin, alginate, chitosan, starch, polyethylene glycol, propylene glycol, triacetin, acetyltriethyl citrate, triethyl citrate, glycerin, or a combination thereof, more specifically It may be maltodextrin.
- the maltodextrin is a white powder based on a porous particle, and is a food additive often used in general foods such as yogurt, sauce, and salad dressing, and can also be used as a porous support during freeze drying of lactic acid bacteria.
- the maltodextrin may be 0.1 wt% to 20 wt% of 100 wt% of the composition for lactic acid bacteria freeze protection, for example, 0.5 wt% to 15 wt%, specifically 1 wt% to 10 wt%, more specifically 2.5 wt% To 7.5% by weight.
- the nitrogen source means a material used as a nitrogen energy source of lactic acid bacteria, which serves to prevent damage to the cells by post-fermentation.
- lactic acid bacteria When lactic acid bacteria are mixed with the composition for freeze protection, lactic acid bacteria living under conditions without an energy source generate organic acids, which cause a decrease in pH, leading to the death of lactic acid bacteria. Therefore, the nitrogen energy source prevents the production of organic acids and the resulting decrease in pH, thereby preventing the death of lactic acid bacteria.
- the nitrogen source is a nitrogen source commonly used in freeze-drying in the technical field to which the present application pertains, and commercially available ones may be purchased and used, and the type is not particularly limited.
- the nitrogen source may be skim milk powder, whey protein, yeast extract, malt extract, beef extract, casein hydrolyzate, malt extract, tryptone, cysteine, peptone, etc.
- the peptone is soypeptone, fish peptone, Proteose peptone, casein peptone, peptone No.3, and the like, and may be representatively soypeptone.
- the soy-peptone may be 0.1% to 20% by weight of 100% by weight of the composition for lactic acid bacteria freeze protection, for example, 0.5% to 15% by weight, specifically 1% to 10% by weight, and more specifically 2.5% by weight To 7.5% by weight.
- the composition for freeze protection of lactic acid bacteria may be applied in the form of a coating agent. That is, the composition for freeze protection of lactic acid bacteria may be mixed with lactic acid bacteria to coat the surface of lactic acid bacteria, thereby protecting lactic acid bacteria from the external environment and increasing storage stability, but is not particularly limited thereto.
- the lactic acid bacteria prepared from the lactic acid bacteria freeze protection composition are as described below.
- This application provides a culture medium for lactic acid bacteria freeze protection.
- the culture medium of the present application may be a culture medium for promoting the growth of lactic acid bacteria.
- the culture medium of the present application may be a culture medium for increasing the thermal stability of lactic acid bacteria.
- the culture medium for lactic acid bacteria freeze protection may be a culture medium for promoting growth of lactic acid bacteria and increasing heat stability.
- the culture medium means a mixture of nutrients required for culturing lactic acid bacteria, and supplies nutrients and growth factors, including water, which is indispensable for the survival and development of lactic acid bacteria.
- the culture medium of the present application contains cysteine or a salt thereof as an active ingredient.
- the cysteine is a kind of sulfur-containing ⁇ -amino acid having a structure of HS-CH 2 CH (NH 2 ) -COOH, and has a sulfhydryl group, thereby forming disulfide bonds with other cysteines.
- the cysteine may be L-cysteine, D-cysteine or L, D-cysteine, and specifically L-cysteine.
- the salt of the cysteine may be any salt of the cysteine, for example, hydrochloride, sulfate, and the like.
- the cysteine or a salt thereof protects the lactic acid bacteria from freezing, thereby minimizing damage or death of the lactic acid bacteria by freezing, and further improving the stability of the lactic acid bacteria so that the lactic acid bacteria can maintain their own activity even after freeze-drying. do.
- the cysteine or a salt thereof not only can significantly increase the production of lactic acid bacteria when lactic acid bacteria are cultured, but also serves to improve the stability of lactic acid bacteria so that the cultured lactic acid bacteria can maintain their own activity.
- the cysteine or a salt thereof is not only as an active ingredient of the culture medium for lactic acid bacteria freeze protection, but also on the other hand, in a culture medium for improving stability of dried, particularly freeze-dried lactic acid bacteria, a culture medium for promoting the growth of lactic acid bacteria, and in such a culture medium. It can be used as a composition for improving the stability of cultured lactic acid bacteria, as well as an active ingredient of a culture medium for increasing the thermal stability of lactic acid bacteria.
- the cysteine or a salt thereof is a content of 0.05% to 10% by weight, specifically 0.05% to 7%, 0.05% to 5%, 0.05% to 3% of 100% by weight of the whole culture medium , Or specifically 0.1% to 10% by weight, 0.1% to 7% by weight, 0.1% to 5% by weight, 0.1% to 3% by weight may be included, and the content of cysteine or a salt thereof Silver lactic acid bacteria can be appropriately adjusted by a person skilled in the art according to the type, size, amount, freeze-drying conditions, and the type or content of other components included in the culture medium.
- the culture medium of the present application in addition to the above-described active ingredients, may further include nutrient components, such as carbon sources, nitrogen sources, personnel, inorganic compounds, amino acids and / or vitamins, which are usually included in the culture medium.
- nutrient components such as carbon sources, nitrogen sources, personnel, inorganic compounds, amino acids and / or vitamins, which are usually included in the culture medium.
- Examples of the carbon source include carbohydrates such as glucose, fructose, sucrose, maltose, mannitol, and sorbitol; Organic acids such as pyruvic acid, lactic acid, and citric acid; amino acids such as glutamic acid, methionine, lysine, and the like.
- natural organic nutrients such as starch hydrolyzate, molasses, blackstrap molasses, rice winter, cassava, sugar cane residue, and corn steep liquor can be used, specifically glucose and sterilized pretreated molasses (i.e. converted to reduced sugars)
- Carbohydrates such as molasses
- Other suitable carbon sources can be used in various ways without limitation. These carbon sources may be used alone or in combination of two or more, but are not limited thereto.
- nitrogen source examples include inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, anmonium carbonate, and ammonium nitrate; Organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, peptone, NZ-amine, meat extract, yeast extract, malt extract, corn steep liquor, casein hydrolyzate, fish or its degradation products, skim soy cake or its degradation products, etc. Can be used. These nitrogen sources may be used alone or in combination of two or more, but are not limited thereto.
- inorganic nitrogen sources such as ammonia, ammonium sulfate, ammonium chloride, ammonium acetate, ammonium phosphate, anmonium carbonate, and ammonium nitrate
- Organic nitrogen sources such as amino acids such as glutamic acid, methionine, glutamine, peptone, NZ-amine, meat extract, yeast extract, malt extract,
- the personnel may include first potassium phosphate, second potassium phosphate, or a corresponding sodium-containing salt.
- sodium chloride, calcium chloride, iron chloride, magnesium sulfate, iron sulfate, manganese sulfate, calcium carbonate, etc. may be used, and other amino acids, vitamins, and / or suitable precursors may be included. These components or precursors may be added batchwise or continuously to the medium, but are not limited thereto.
- a compound such as ammonium hydroxide, potassium hydroxide, ammonia, phosphoric acid, sulfuric acid, etc. can be added to the culture medium to adjust the pH of the culture medium, and an antifoaming agent such as a fatty acid polyglycol ester can be used to suppress the formation of bubbles during culture.
- an antifoaming agent such as a fatty acid polyglycol ester can be used to suppress the formation of bubbles during culture.
- oxygen or oxygen-containing gas may be injected into the culture medium, or nitrogen, hydrogen, or carbon dioxide gas may be injected without gas injection or to maintain the anaerobic and aerobic state. Does not work.
- the culture medium may be solid or liquid.
- Lactic acid bacteria prepared from the culture medium is as described below.
- This application provides a method for producing a lactic acid bacteria agent, specifically a lactic acid bacteria agent having thermal stability.
- the production method of the lactic acid bacteria of the present application includes mixing the lactic acid bacteria with a composition containing cysteine or a salt thereof to prepare a mixture, and freeze-drying the mixture to form a powder.
- the composition containing the cysteine or a salt thereof may use a composition for lyophilizing lactic acid bacteria according to the present application.
- composition comprising the cysteine or a salt thereof may use a culture medium according to the present application, such as a culture medium for lyophilization of lactic acid bacteria.
- the lactic acid bacteria are mixed with a composition containing cysteine or a salt thereof, such as the composition for freeze protection of the lactic acid bacteria.
- the lactic acid bacteria and the composition for freeze protection of lactic acid bacteria may be mixed in a ratio of 1: 0.1 to 1: 5, specifically 1: 0.5 to 1: 4, and more specifically 1: 1 to 1: 3 by weight. At the mixing ratio, lactic acid bacteria can be effectively protected from freezing, and powdering can be efficiently performed.
- the mixing time of the lactic acid bacteria and the lactic acid bacteria freeze protection composition specifically, when the cysteine or a salt thereof is administered in the culture step of the lactic acid bacteria, the culture step of the lactic acid bacteria during the entire process of the manufacturing method of the lactic acid bacteria can be administered anywhere without limitation. And, for example, before culturing the lactic acid bacteria, it may be administered to at least one of the lag phase, exponential phase (exponential phase), and stationary phase (stationary phase) of the lactic acid bacteria.
- the lactic acid bacteria may be sufficiently cultured by conventional means and methods, and recovered by a conventional method.
- the culture means growing the lactic acid bacteria under appropriately controlled environmental conditions.
- the culturing process may be performed according to a suitable medium and culture conditions known in the art to which this application belongs. This culture process can be appropriately adjusted by a person skilled in the art according to the selected strain.
- the lactic acid bacteria may be cultured in the form of batch, continuous, fed-batch, and the like.
- the culture temperature of the lactic acid bacteria may be a temperature of 20 °C to 50 °C, specifically 30 °C to 40 °C.
- the culture time of the lactic acid bacteria can be cultured for 1 hour to 100 hours, specifically 5 hours to 50 hours.
- the step of recovering the cells of the lactic acid bacteria may be used to recover the desired cells from the medium using an appropriate method known in the art to which the present application belongs, depending on the culture type of the lactic acid bacteria as described above. For example, centrifugation, filtration, treatment with a crystallization protein precipitator (salt-out method), extraction, ultrasonic crushing, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography It can be used in combination of various chromatography, HPLC and methods.
- the recovery step may include an additional purification process, and using the appropriate method known in the art to which the present application pertains, the recovered lactic acid bacteria may be further purified.
- the mixture of the lactic acid bacteria and the lactic acid bacteria freeze protection composition is lyophilized to powder.
- the process of pulverizing the mixture of the lactic acid bacteria and the lactic acid bacteria freeze protection composition may be performed through freeze drying, which is generally used in the conventional food field.
- the freeze drying may be performed at a temperature of -70 ° C to 30 ° C, specifically -70 ° C to -40 ° C.
- the freeze-drying may be performed as a process of removing water by thawing in a freeze dryer after freezing under conditions of cooling for 3 hours to 48 hours, specifically 6 hours to 36 hours, and more specifically 12 hours to 24 hours. .
- lactic acid bacteria By mixing the lactic acid bacteria with the composition for freeze protection of lactic acid bacteria of the present application and freeze-drying as described above, stability can be improved to produce a lactic acid bacteria agent that maintains the activity of lactic acid bacteria as much as possible.
- the method for preparing the lactic acid bacteria may further include mixing the lactic acid bacteria with the composition for freeze protection of the lactic acid bacteria, and culturing the lactic acid bacteria cells using the mixture before freeze-drying the mixture. .
- the lactic acid bacteria are mixed with the composition for freeze protection of the lactic acid bacteria, the mixture is used to cultivate the cells of the lactic acid bacteria, recover the cells of the cultured lactic acid bacteria, and recover the lactic acid bacteria cells Powdering.
- the culture means growing the lactic acid bacteria under appropriately controlled environmental conditions.
- the culturing process may be performed under suitable culturing conditions known in the art.
- This culture process can be appropriately adjusted by a person skilled in the art according to the selected strain.
- the lactic acid bacteria in the form of batch, continuous, fed-batch, etc., may be carried out at a temperature of 20 °C to 50 °C, specifically 30 °C to 40 °C.
- the culture may be incubated for 1 hour to 100 hours, specifically 5 hours to 50 hours.
- the step of recovering the cells of the lactic acid bacteria may be used to recover the desired cells from the medium using an appropriate method known in the art to which the present application belongs, depending on the culture type of the lactic acid bacteria as described above. For example, centrifugation, filtration, treatment with a crystallization protein precipitator (salt-out method), extraction, ultrasonic crushing, ultrafiltration, dialysis, molecular sieve chromatography (gel filtration), adsorption chromatography, ion exchange chromatography, affinity chromatography It can be used in combination of various chromatography, HPLC and methods.
- the recovery step may include an additional purification process, and using the appropriate method known in the art to which the present application pertains, the recovered lactic acid bacteria may be further purified.
- the lactic acid bacteria cells recovered as described above may be mixed with a composition containing a cryoprotectant, a porous support or a nitrogen source, without cysteine or a salt thereof.
- a composition containing a cryoprotectant, a porous support or a nitrogen source without cysteine or a salt thereof.
- the description of the cryoprotectant, the porous support and the nitrogen source is the same as described for the composition for lyophilizing the lactic acid bacteria.
- the process of pulverizing the recovered lactic acid bacteria cells may be performed through a powdering method generally used in the conventional food field, for example, it may be performed by freeze-drying the recovered lactic acid bacteria cells.
- the freeze drying is performed at a temperature of -70 ° C to 30 ° C, specifically -70 ° C to -40 ° C for 3 hours to 48 hours, specifically 6 hours to 36 hours, and more specifically 12 hours to 24 hours. After freezing, it can be performed by thawing in a freeze dryer to remove moisture.
- lactic acid bacteria By culturing the lactic acid bacteria in a mixture with the composition for lactic acid bacteria freeze protection as described above and pulverizing the lactic acid bacteria cells recovered therefrom, stability can be improved to produce a lactic acid bacteria agent that maintains the activity of the lactic acid bacteria as much as possible.
- the composition for lactic acid bacteria freeze protection in the above-described manufacturing method It is as described above as a manufacturing method using.
- the stability of the lactic acid bacteria prepared according to the production method of the lactic acid bacteria of the present application will be described later.
- Another aspect of the present application provides a method of promoting the growth of lactic acid bacteria, a method of regulating energy metabolism of lactic acid bacteria, and a method of increasing the thermal stability of lactic acid bacteria.
- the method for promoting the growth of lactic acid bacteria of the present application, the method for regulating the energy metabolism of lactic acid bacteria, and the method for increasing the thermal stability of lactic acid bacteria include lactic acid bacteria, the above-described culture medium, for example, culture for promoting growth of lactic acid bacteria of the present application It may include culturing in a medium and / or mixing with the composition for lyophilizing the lactic acid bacteria described above and culturing in the mixture.
- the specific method can be carried out in the same manner as the method for producing the lactic acid bacteria described above.
- the energy production mechanism is not limited thereto, Energy can be produced by 'breathing'.
- the conditions for minimizing oxygen exposure are changed to culture conditions, for example, oxygen / nitrogen substitution of a fermenter is performed, but cysteine or a salt thereof in the present application
- culture conditions for example, oxygen / nitrogen substitution of a fermenter is performed, but cysteine or a salt thereof in the present application
- Lactic acid bacteria promoted growth according to the present application has the effect of improving stability and maintaining a high level of lactic acid bacteria for a long period of time.
- the stability of the lactic acid bacteria prepared according to the production method of the lactic acid bacteria of the present application will be described later.
- This application provides a lactic acid bacteria agent, specifically a lactic acid bacteria agent having thermal stability.
- the lactic acid bacteria of the present application is lactic acid bacteria; And cysteine or salts thereof.
- the cysteine is a kind of sulfur-containing ⁇ -amino acid having a structure of HS-CH 2 CH (NH 2 ) -COOH, and has a sulfhydryl group, thereby forming disulfide bonds with other cysteines.
- the cysteine may be L-cysteine, D-cysteine or L, D-cysteine, and specifically L-cysteine.
- the salt of the cysteine may be any salt of the cysteine, specifically, a hydrochloride, sulfate, or the like.
- the lactic acid bacteria are granules, powders, powders, granules, needles, emulsions, fluids, tablets, pills, capsules, granules, ointments, suppositories, injection solutions, inhalants, aerosols, suspensions, syrups, emulsions, soft capsules, hard capsules, It may be in the form of elixirs, troches, lozenge, etc., and may be specifically in the form of freeze-dried powder.
- cysteine or a salt thereof lactic acid bacteria are protected from freezing to minimize damage or death of lactic acid bacteria, and further, even after being prepared in powder form, lactic acid bacteria can maintain their intrinsic activity.
- the lactobacillus of the present application is stored at 40 ° C for 4 weeks, 45% or more compared to the initial storage, specifically 50% or more, 50.5% or more, 51% or more, 55% or more, 60% or more, 65% or more , 70% or more, 75% or more, or 77% or more.
- 45% or more of the initial storage specifically 50% or more, 51% or more, 52% or more, 55% or more, 60% or more, 65% or more, 70% or more , 75% or more, 80% or more, or 81% or more.
- the initial storage may be on day 0 or immediately before storage.
- the growth of lactic acid bacteria can be promoted when the lactic acid bacteria are cultured by the cysteine or a salt thereof.
- the OD (Optical Density) value measured using a spectrophotometer when the lactic acid bacteria were cultured at 37 ° C in the presence of cysteine or a salt thereof and diluted 20 times is 0.5 or more after 7 hours, specifically 0.7 or more, 0.9 Or more, 1.0 or more, or 1.2 or more.
- after 8 hours it may represent 0.6 or more, 0.8 or more, 1.0 or more, 1.2 or more, or 1.3 or more.
- after 9 hours 0.7 or more, 0.8 or more, 0.9 or more, 1.0 or more, 1.2 or more, 1.3 or more, or 1.4 or more.
- after 10 hours it may represent 0.8 or more, 1.0 or more, 1.2 or more, 1.4 or more, or 1.5 or more. In one aspect, after 11 hours, it may represent 1.0 or more, 1.1 or more, 1.2 or more, 1.3 or more, 1.4 or more, or 1.5 or more.
- the viable cell count is not limited thereto, but after 7 hours, 1.5x10 ⁇ 9 or more, 2.0x10 ⁇ 9 or more, 2.5x10 ⁇ 9 Or more, 3.0x10 ⁇ 9 or more, 3.5x10 ⁇ 9 or more, 4.0x10 ⁇ 9 or more, 5.0x10 ⁇ 9 or more, or 5.5x10 ⁇ 9 or more.
- after 9 hours it may be 3.0x10 ⁇ 9 or more, 5.0x10 ⁇ 9 or more, 7.0x10 ⁇ 9 or more, 9.0x10 ⁇ 9 or more, or 9.5x10 ⁇ 9 or more.
- after 10 hours 4.0x10 ⁇ 9 or more, 5.0x10 ⁇ 9 or more, 7.0x10 ⁇ 9 or more, 9.0x10 ⁇ 9 or more, 9.5x10 ⁇ 9 or more, 1.0x10 ⁇ 10 or more, or 1.2x10 ⁇ 10 or more .
- Lactobacillus plantarum CJLP133 strain was cultured at 37 ° C. for 18 to 24 hours using MRS liquid medium (Difco, USA), and then the supernatant was discarded using a centrifuge to recover only lactic acid bacteria.
- Example 1-1 Example 1-2
- Example 1-3 Example 1-4 Cysteine hydrochloride 0.1 0.5 One 5 Trehalose 20 20 20 20 20 Maltodextrin 5 5 5 5 Soy Peptone 5 5 5 5 5 water Balance Balance Balance Balance total 100 100 100 100 100 100 100
- the Lactobacillus plantarum CJLP133 strain disclosed in Korean Patent Publication No. 1,486,999 was cultured at 37 ° C. for 18 to 24 hours using MRS liquid medium (Difco, USA) containing 0.1% by weight of cysteine hydrochloride. , The supernatant was discarded using a centrifuge and only lactic acid bacteria were recovered.
- the lactic acid bacteria cells recovered as described above were mixed in a weight ratio of 1: 2 with the composition for freeze protection of lactic acid bacteria prepared by mixing and sterilizing trehalose, maltodextrin, soypeptone, and water in the contents shown in Table 2 below.
- Lactobacillus plantarum CJLP133 strain was cultured in MRS liquid medium (Difco, USA) containing 0.1% cysteine hydrochloride for 11 hours at 37 ° C.
- the components of the MRS medium containing cysteine hydrochloride are shown in Table 3, and the pH lowered during the culture was set to neutralize to pH 5.95 through an automatic ammonia water feeding system.
- L-Cysteine Monohydrochloride 1 g Proteose Peptone 10 g Beef Extract 10 g Yeast Extract 5 g Dextrose 20 g Polysorbate80 1 g Ammonium Citrate 2 g Sodium Acetate 5 g Magnesium Sulfate 0.1 g Manganese Sulfate 0.05 g Dipotassium Phosphate 2 g water 1,000 mL
- Lactobacillus plantarum CJLP133 strain was cultured at 37 ° C. for 18 to 24 hours using MRS liquid medium (Difco, USA), and then the supernatant was discarded using a centrifuge to recover only lactic acid bacteria.
- the lactic acid bacteria cells recovered as described above were mixed in a weight ratio of 1: 2 with the composition for lactic acid bacteria freeze protection prepared by mixing and sterilizing trehalose, maltodextrin, soypeptone, and water in the amounts shown in Table 2.
- Lactobacillus plantarum CJLP133 strain was cultured in MRS liquid medium (Difco, USA) without 0.1% cysteine hydrochloride for 11 hours at 37 ° C.
- the MRS medium components are shown in Table 4, and the pH lowered during the culture was set to neutralize to pH 5.95 through an automatic ammonia water feeding system.
- the survival rate under the harsh conditions of Examples 1-1, 2, and 1 was analyzed.
- the freeze-dried lactic acid bacteria powder gradually decreases in activity with storage temperature and storage period. In general, temperature, oxygen, moisture, etc. are factors influencing activity.
- the freeze-dried lactic acid bacteria powder is very hygroscopic, and a lot of content decreases at the initial stage of storage.
- there are various methods for deoxidizing or applying a deoxidizer to packaging materials but ultimately, a lot of difference is seen in the storage period depending on the degree of stability of the lactic acid bacteria powder itself. Therefore, in order to alleviate the hygroscopicity due to the characteristics of the raw materials, each sample was individually packaged and stored in an aluminum pouch, and stored at 40 ° C for 4 weeks to analyze the survival rate under harsh conditions.
- the samples of the lactic acid bacteria powders prepared in Examples 1-1, 2, and 1 were sealed in an aluminum pouch packaging and individually packaged, and each sample was sealed in an incubator at 40 ° C. for 4 weeks. Kept. After a predetermined time, the experimental group samples were diluted in a saline buffer at a magnification of 1: 100, placed in a sterile bag, and then homogenized. Samples subjected to continuous dilution with a saline buffer solution were plated on MRS agar plates. Plates were collected and counted after standing culture for 24 hours under aerobic conditions at 37 ° C, and the results are shown in Table 5 below. The numbers listed in Table 5 below indicate the survival rate (%) compared to the initial lactic acid bacteria.
- Example 1-1 As a result of measuring the activity of lactic acid bacteria over time by applying harsh conditions, in the case of Example 1-1 using a cryoprotective composition containing cysteine hydrochloride or Example 2 using a culture medium containing cysteine hydrochloride, Compared to Comparative Example 1, which did not contain cysteine hydrochloride, it was confirmed to exhibit a much higher survival rate of lactic acid bacteria.
- Example 1-1 Example 1-2
- Example 1-3 Example 1-4
- Lactic acid bacteria culture evaluation was conducted by O.D. According to the value (Optical density) measurement method, the lactic acid bacteria culture solution was diluted 20-fold at 600 nm using a spectrophotometer (Spectrophotometer, NanoPhotometer, IMPLEN).
- Example 3 cultured in a culture medium containing cysteine hydrochloride compared to Comparative Example 2 cultured in a culture medium containing no cysteine hydrochloride, the culture speed of lactic acid bacteria was significantly higher. Confirmed. From these results, it was confirmed that the ability to promote the growth of lactic acid bacteria by cysteine hydrochloride is excellent.
- the lactic acid bacteria culture solution was diluted with sterile menstrual water to form 30 to 300 colonies on the MRS agar plate medium, and then incubated at 37 ° C for 24 hours. The number of colonies displayed after incubation was counted and calculated as the number of live bacteria per mL.
- Example 1 which was cultured in a culture medium containing cysteine hydrochloride, compared with Comparative Example 1, which was cultured in a culture medium not containing cysteine hydrochloride, it was confirmed that the number of lactic acid bacteria was significantly higher. From these results, it was confirmed that the ability to promote lactic acid bacteria growth by cysteine hydrochloride is excellent.
- a preferred embodiment of the present application has been exemplarily described, but the scope of the present application is not limited to the specific embodiment as described above. Those skilled in the art will be able to appropriately change within the scope described in the claims of the present application.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
성분 | 함량(중량%) | |||
실시예 1-1 | 실시예 1-2 | 실시예 1-3 | 실시예 1-4 | |
시스테인염산염 | 0.1 | 0.5 | 1 | 5 |
트레할로오스 | 20 | 20 | 20 | 20 |
말토덱스트린 | 5 | 5 | 5 | 5 |
소이펩톤 | 5 | 5 | 5 | 5 |
물 | 잔부 | 잔부 | 잔부 | 잔부 |
총합 | 100 | 100 | 100 | 100 |
성분 | 함량(중량%) |
트레할로오스 | 20 |
말토덱스트린 | 5 |
소이펩톤 | 5 |
물 | 잔부 |
총합 | 100 |
성분 | 함량 |
L-Cysteine Monohydrochloride | 1 g |
Proteose Peptone | 10 g |
Beef Extract | 10 g |
Yeast Extract | 5 g |
Dextrose | 20 g |
Polysorbate80 | 1 g |
Ammonium Citrate | 2 g |
Sodium Acetate | 5 g |
Magnesium Sulfate | 0.1 g |
Manganese Sulfate | 0.05 g |
Dipotassium Phosphate | 2 g |
물 | 1,000 mL |
성분 | 함량 |
Proteose Peptone | 10 g |
Beef Extract | 10 g |
Yeast Extract | 5 g |
Dextrose | 20 g |
Polysorbate80 | 1 g |
Ammonium Citrate | 2 g |
Sodium Acetate | 5 g |
Magnesium Sulfate | 0.1 g |
Manganese Sulfate | 0.05 g |
Dipotassium Phosphate | 2 g |
물 | 1,000 mL |
시점 | 생존률(%) | ||
비교예 1 | 실시예 1-1 | 실시예 2 | |
초기 | 100.0 | 100.0 | 100.0 |
1주 | 54.7 | 72.7 | 89.0 |
2주 | 35.9 | 64.9 | 91.5 |
3주 | 40.9 | 52.2 | 81.8 |
4주 | 38.0 | 51.0 | 77.4 |
시점 | 생존률(%) | |||
실시예 1-1 | 실시예 1-2 | 실시예 1-3 | 실시예 1-4 | |
초기 | 100.0 | 100.0 | 100.0 | 100.0 |
1주 | 72.7 | 93.0 | 89.2 | 91.7 |
2주 | 64.9 | 75.2 | 82.3 | 88.5 |
3주 | 52.2 | 74.3 | 78.7 | 81.1 |
4주 | 51.0 | 73.4 | 77.5 | 75.5 |
O.D. | 비교예 2 | 실시예 3 |
0 hr | 0 | 0 |
7 hr | 0.446 | 1.282 |
8 hr | 0.536 | 1.396 |
9 hr | 0.664 | 1.457 |
10 hr | 0.792 | 1.528 |
11 hr | 0.937 | 1.510 |
CFU/ml | 비교예 2 | 실시예 3 |
0hr | 0 | 0 |
7hr | 1.2 x 10^9 | 5.9 x 10^9 |
8hr | 2.0 x 10^9 | 9.2 x 10^9 |
9hr | 2.8 x 10^9 | 1.0 x 10^10 |
10hr | 3.3 x 10^9 | 1.2 x 10^10 |
11hr | 4.2 x 10^9 | 1.2 x 10^10 |
Claims (17)
- 시스테인 또는 이의 염을 유효성분으로 포함하는, 유산균 동결 보호용 조성물.
- 청구항 1에 있어서,상기 시스테인염의 염은 염산염인, 유산균 동결 보호용 조성물.
- 청구항 1에 있어서,상기 시스테인 또는 이의 염은 0.01 중량% 내지 10 중량%의 함량으로 포함되는, 유산균 동결 보호용 조성물.
- 청구항 1에 있어서,트레할로오스, 말토덱스트린 및 소이펩톤으로 이루어진 군에서 선택되는 적어도 하나를 더 포함하는, 유산균 동결 보호용 조성물.
- 청구항 1 내지 4 중 어느 한 항에 있어서,유산균의 열안정성을 갖는 것인, 유산균 동결 보호용 조성물.
- 시스테인 또는 이의 염을 유효성분으로 포함하는, 유산균 동결 보호용 배양 배지.
- 청구항 6에 있어서,상기 시스테인 또는 이의 염은 0.01 중량% 내지 10 중량%의 함량으로 포함되는, 유산균 동결 보호용 배양 배지.
- 청구항 6에 있어서,코엔자임 Q10, 비타민 C, 비타민 E 및 비타민 B2로 이루어진 군으로부터 선택되는 적어도 어느 하나를 더 포함하는, 유산균 동결 보호용 배양 배지.
- 청구항 6에 있어서,유산균의 생육 촉진 및 열안정성 증가 중 적어도 하나의 효능을 더 갖는 것인, 유산균 동결 보호용 배양 배지.
- 유산균을,시스테인 또는 이의 염을 포함하는 조성물과 혼합하여 혼합물을 준비하고, 상기 혼합물을 동결 건조하여 분말화하는 것을 포함하는, 유산균제의 제조 방법.
- 청구항 10에 있어서,상기 혼합물을 동결건조 하기 전 혼합물을 이용하여 유산균 균체를 배양하는 것을 추가로 포함하는 것인 유산균제의 제조 방법.
- 유산균; 및 시스테인 또는 이의 염;을 포함하는 열안정성을 갖는 유산균제.
- 청구항 12에 있어서,상기 유산균제는 그래뉼, 분말, 산제, 과립제, 침제, 유제, 유동제, 정제, 환제, 캅셀제, 과립제, 연고, 좌제, 주사액, 흡입제, 에어로졸, 현탁제, 시럽제, 에멀젼, 연질 캡슐, 경질 캡슐, 엘릭시르제(elixirs), 트로치제(troches) 또는 로젠제(lozenge) 형태인 유산균제.
- 청구항 12에 있어서,상기 유산균제는 동결 건조된 분말의 형태인 유산균제.
- 청구항 12 내지 청구항 14 중 어느 한 항에 있어서,상기 유산균제는 40℃에서 4주간 보관한 후의 유산균 생존률이 45% 이상인 유산균제.
- 유산균을, 청구항 6 내지 청구항 9 중 어느 한 항의 배양 배지에서 배양하는 것을 포함하는, 유산균의 생육을 촉진하는 방법.
- 유산균을, 청구항 6 내지 청구항 9 중 어느 한 항의 배양 배지에서 배양하는 것을 포함하는, 유산균의 열안정성을 증가하는 방법.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3118263A CA3118263A1 (en) | 2018-10-30 | 2019-10-28 | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria |
CN201980080487.XA CN113166715A (zh) | 2018-10-30 | 2019-10-28 | 半胱氨酸或半胱氨酸的盐用于保护乳酸菌防冻的用途 |
AU2019369917A AU2019369917C1 (en) | 2018-10-30 | 2019-10-28 | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria |
JP2021548490A JP2022509472A (ja) | 2018-10-30 | 2019-10-28 | 乳酸菌の凍結保護のためのシステインまたはその塩の用途(use of cysteine or salt thereof for cryoprotecting lactic acid bacteria) |
SG11202104478QA SG11202104478QA (en) | 2018-10-30 | 2019-10-28 | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria |
EP19880216.7A EP3875577A4 (en) | 2018-10-30 | 2019-10-28 | USE OF CYSTEINE OR A CORRESPONDING SALT FOR THE CRYOPROTECTION OF LACTIC BACTERIA |
US17/290,526 US20210317401A1 (en) | 2018-10-30 | 2019-10-28 | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria |
JP2023030196A JP2023073258A (ja) | 2018-10-30 | 2023-02-28 | 乳酸菌の凍結保護のためのシステインまたはその塩の用途(use of cysteine or salt thereof for cryoprotecting lactic acid bacteria) |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2018-0131242 | 2018-10-30 | ||
KR20180131242 | 2018-10-30 | ||
KR20190047299 | 2019-04-23 | ||
KR10-2019-0047299 | 2019-04-23 | ||
KR10-2019-0134072 | 2019-10-25 | ||
KR1020190134072A KR102447791B1 (ko) | 2018-10-30 | 2019-10-25 | 유산균의 동결 보호를 위한 시스테인 또는 이의 염의 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020091334A1 true WO2020091334A1 (ko) | 2020-05-07 |
Family
ID=70464193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2019/014257 WO2020091334A1 (ko) | 2018-10-30 | 2019-10-28 | 유산균의 동결 보호를 위한 시스테인 또는 이의 염의 용도 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020091334A1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113604402A (zh) * | 2021-08-30 | 2021-11-05 | 江苏恒顺醋业股份有限公司 | 一种特异性的乳酸菌培养基及其培养方法和应用 |
CN113652359A (zh) * | 2021-07-05 | 2021-11-16 | 上海商学院 | 一种乳酸菌冻干粉、制备方法及其冻干保护剂 |
CN114774281A (zh) * | 2022-02-25 | 2022-07-22 | 河南省商业科学研究所有限责任公司 | 一种保加利亚乳杆菌冻干用复合保护剂 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0285979A2 (en) * | 1987-04-06 | 1988-10-12 | Rhone-Poulenc Inc. | Method for enhancing the stability of freeze-dried cultures |
KR20060108964A (ko) * | 2005-04-14 | 2006-10-19 | 정명준 | 엔테로코커스 패칼리스 cbt―sl(5), 이를 이용한항균 배양액 분리농축물의 제조 방법 및 이를 포함하는조성물 |
US20090324776A1 (en) * | 2006-07-13 | 2009-12-31 | Compagnie Gervais Danone | Cysteine granules and use thereof as bifidobacterium animalis lactis growth stimulants |
KR101075558B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101075557B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101178217B1 (ko) | 2009-10-28 | 2012-09-07 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101255050B1 (ko) | 2009-07-14 | 2013-04-16 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101486999B1 (ko) | 2009-07-22 | 2015-01-28 | 씨제이제일제당 주식회사 | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101604633B1 (ko) * | 2015-08-28 | 2016-03-18 | 주식회사 락토메이슨 | 유산균 배지 조성물 및 이를 이용한 유산균 분말의 제조 방법 |
-
2019
- 2019-10-28 WO PCT/KR2019/014257 patent/WO2020091334A1/ko unknown
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0285979A2 (en) * | 1987-04-06 | 1988-10-12 | Rhone-Poulenc Inc. | Method for enhancing the stability of freeze-dried cultures |
KR20060108964A (ko) * | 2005-04-14 | 2006-10-19 | 정명준 | 엔테로코커스 패칼리스 cbt―sl(5), 이를 이용한항균 배양액 분리농축물의 제조 방법 및 이를 포함하는조성물 |
US20090324776A1 (en) * | 2006-07-13 | 2009-12-31 | Compagnie Gervais Danone | Cysteine granules and use thereof as bifidobacterium animalis lactis growth stimulants |
KR101075558B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101075557B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101255050B1 (ko) | 2009-07-14 | 2013-04-16 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101486999B1 (ko) | 2009-07-22 | 2015-01-28 | 씨제이제일제당 주식회사 | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101178217B1 (ko) | 2009-10-28 | 2012-09-07 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
KR101604633B1 (ko) * | 2015-08-28 | 2016-03-18 | 주식회사 락토메이슨 | 유산균 배지 조성물 및 이를 이용한 유산균 분말의 제조 방법 |
Non-Patent Citations (3)
Title |
---|
CELIK, 0. F.: "Factors influencing the stability of freeze-dried stress-resilient and stress-sensitive strains of bifidobacteria", JOURNAL OF DAIRY SCIENCE, 2013, pages 3506 - 3516 ; 3507, 3508, 3509, XP055702666 * |
CHAMPAGNE ET AL., FOOD RESEARCH INTERNATIONAL, vol. 29, 1996, pages 555 - 562 |
FONT DE VALDEZ, G. ET AL.: "Comparative study of the efficiency of some additives in protecting lactic acid bacteria against freeze-drying", CRYOBIOLOGY, 1983, pages 560 - 566, XP001315085 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113652359A (zh) * | 2021-07-05 | 2021-11-16 | 上海商学院 | 一种乳酸菌冻干粉、制备方法及其冻干保护剂 |
CN113604402A (zh) * | 2021-08-30 | 2021-11-05 | 江苏恒顺醋业股份有限公司 | 一种特异性的乳酸菌培养基及其培养方法和应用 |
CN114774281A (zh) * | 2022-02-25 | 2022-07-22 | 河南省商业科学研究所有限责任公司 | 一种保加利亚乳杆菌冻干用复合保护剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020004933A1 (ko) | 구연산염을 포함하는 유산균 동결 보호용 조성물 | |
WO2016200048A1 (ko) | 유산균의 생존율, 저장안정성, 내산성 또는 내담즙성을 증가시키는 방법 | |
WO2020091334A1 (ko) | 유산균의 동결 보호를 위한 시스테인 또는 이의 염의 용도 | |
WO2012060579A2 (ko) | 항균용 유산균 사균체 및 이의 제조방법 | |
KR101604633B1 (ko) | 유산균 배지 조성물 및 이를 이용한 유산균 분말의 제조 방법 | |
WO2017105140A1 (ko) | 장내 생존율이 증대된 유산균의 코팅 방법 | |
WO2020050460A1 (ko) | 염증성 장질환 예방 또는 치료용 약학적 조성물 | |
CN108148789B (zh) | 一种鼠李糖乳杆菌及其在制备细菌素中的应用 | |
WO2018186700A1 (ko) | 실크 피브로인으로 코팅되어 장내 정착성이 향상된 유산균을 포함하는 조성물 | |
WO2010087551A1 (ko) | 멤브레인 생물반응기를 이용한 고농도 유산균의 생산방법 및 유산균 동결건조 분말의 제조방법 | |
JP2023073258A (ja) | 乳酸菌の凍結保護のためのシステインまたはその塩の用途(use of cysteine or salt thereof for cryoprotecting lactic acid bacteria) | |
WO2014069874A1 (ko) | 녹차 유산균을 포함하는 피부 각질 제거용 조성물 | |
WO2018012941A2 (ko) | 가스발생량이 낮은 류코노스톡 메센테로이드 cjlm119 균주 및 이를 이용한 김치의 제조방법 | |
WO2019027073A1 (ko) | 바실러스 서브틸리스 및 바실러스 리체니포미스를 포함하는 사료 첨가제, 상기 첨가제를 포함하는 사료 조성물 및 상기 사료첨가제의 제조 방법 | |
WO2019045493A1 (en) | NOVEL BACILLUS AMYLOLIC FACTOR STRAIN AND PROCESS FOR PREPARING A FERMENTED SOY PRODUCT USING THE SAME | |
CN115975858A (zh) | 一株嗜酸乳杆菌ls001及其培养方法与抑制幽门螺杆菌的应用 | |
WO2019013382A1 (ko) | 바실러스 서브틸리스 및 바실러스 리체니포미스를 포함하는 사료 첨가제, 상기 첨가제를 포함하는 사료 조성물 및 상기 사료첨가제의 제조 방법 | |
KR102290654B1 (ko) | 동결보호용 조성물 및 이를 포함하는 유산균제 | |
WO2012008760A9 (ko) | 바실러스속 고온성 균주 및 이를 이용한 대두박이 함유된 어분의 제조방법 | |
WO2023200262A1 (ko) | 칼슘-알긴산 비드로 포집된 유산균의 제조 방법 | |
US8501456B2 (en) | Method for making lactic acid bacteria composition | |
KR102384604B1 (ko) | 저분자 콜라겐 펩타이드를 포함하는 프로바이오틱스-코팅 동결보존용 조성물 및 동결 보존 방법 | |
WO2021261929A1 (ko) | 신규 락토바실러스 루테리 균주 및 이의 용도 | |
WO2018012943A1 (ko) | 가스발생량이 낮은 류코노스톡 메센테로이드 cjlm627 균주 및 이를 이용한 김치의 제조방법 | |
WO2024090679A1 (ko) | 크로노박터 사카자키에 대해 사멸능을 갖는 신규 박테리오파지, 캡슐화된 박테리오파지 분말의 제조방법, 박테리오파지 분말 및 이를 포함하는 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19880216 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021548490 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 3118263 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2019369917 Country of ref document: AU Date of ref document: 20191028 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019880216 Country of ref document: EP Effective date: 20210531 |